Merrimack Pharmaceuticals (United States)
- World rank, all time
- #22,666 of 42,892
- Rank in United States
- #4,877 of 8,685
- Research works
- 228 ▼ 63% vs 2013–17
- Citations
- 5.9k 25.8 per fractional work
- Top-10% rate
- 6.5% record average 16.5%
- Open access
- 23% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.5×. Every wedge is a field page.
Who are the top researchers at Merrimack Pharmaceuticals (United States)?
Ranked on the composite score, Bart S. Hendriks, Charlotte F. McDonagh and Birgit Schoeberl lead among researchers whose main affiliation is Merrimack Pharmaceuticals (United States).
- 1 Bart S. Hendriks United States · #302,215 worldwide 115 citations · 20 works
- 2 Charlotte F. McDonagh United States · #689,664 worldwide 41 citations · 16 works
- 3 Birgit Schoeberl United States · #897,088 worldwide 69 citations · 15 works
- 4 Jonathan B. Fitzgerald United States · #932,778 worldwide 46 citations · 18 works
- 5 Daryl C. Drummond United States · #1,221,123 worldwide 20 citations · 20 works
Which keywords describe research at Merrimack Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Glycosylation, Monoclonal Antibodies, Breast Cancer, Therapeutic Antibodies, Antibody Engineering, Fc Receptors and Monoclonal Antibody.
- EGFR Mutations
- PET Imaging
- Virtual Screening
- Medicinal Chemistry
- Pharmacokinetics
- Glycans
- Polymeric Nanoparticles
- Surface Engineering
- Metastatic Breast Cancer
- Metabolism
- Clinical Trials
- Nanoparticles
- Immunotherapy
- Cancer Therapy
- EGFR
- Trastuzumab
- Monoclonal Antibody
- Antibody Engineering
- Breast Cancer
- Glycosylation
- Chemotherapy
- Monoclonal Antibodies
- Therapeutic Antibodies
- Fc Receptors
- Receptor tyrosine kinases
- Cancer
- HER2
- Targeted Therapy
- Tumor Targeting
- Tumor Microenvironment
- Magnetic Nanoparticles
- Biomedical Applications
- Drug Delivery
- Nanocarriers
- Immune System
- Mucins
- Signaling
- Molecular Docking
- Immunity
- ALK Inhibitors
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy36▲ 22×14 topics
- Glycosylation32▲ 64×3 topics
- Monoclonal Antibodies25▲ 77×3 topics
- Breast Cancer25▲ 39×6 topics
- Therapeutic Antibodies25▲ 84×2 topics
- Antibody Engineering23▲ 102×1 topic
- Fc Receptors23▲ 102×1 topic
- Monoclonal Antibody22▲ 142×2 topics
- Receptor tyrosine kinases22▲ 222×2 topics
- Trastuzumab22▲ 222×2 topics
- Cancer21▲ 6.6×24 topics
- EGFR21▲ 301×1 topic
- HER221▲ 301×1 topic
- Cancer Therapy16▲ 11×12 topics
- Targeted Therapy15▲ 30×4 topics
- Immunotherapy15▲ 10×9 topics
- Tumor Targeting15▲ 48×3 topics
- Nanoparticles13▲ 4.3×7 topics
- Tumor Microenvironment10▲ 13×7 topics
- Clinical Trials10▲ 7.2×7 topics
- Magnetic Nanoparticles8▲ 35×2 topics
- Metabolism8▲ 5.5×6 topics
- Biomedical Applications8▲ 3.3×4 topics
- Metastatic Breast Cancer8▲ 52×2 topics
- Drug Delivery8▲ 7.2×3 topics
- Surface Engineering8▲ 30×2 topics
- Nanocarriers8▲ 77×1 topic
- Polymeric Nanoparticles8▲ 77×1 topic
- Immune System8▲ 10.0×2 topics
- Glycans7▲ 40×1 topic
- Mucins7▲ 40×1 topic
- Pharmacokinetics7▲ 11×3 topics
- Signaling7▲ 25×4 topics
- Medicinal Chemistry6▲ 7.3×4 topics
- Molecular Docking6▲ 18×1 topic
- Virtual Screening6▲ 37×1 topic
- Immunity6▲ 7.3×5 topics
- PET Imaging6▲ 11×4 topics
- ALK Inhibitors5▲ 42×1 topic
- EGFR Mutations5▲ 42×1 topic
Which research topics does Merrimack Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques and Lipid Membrane Structure and Behavior.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 0 works
- 2 RNA Interference and Gene Delivery Molecular Biology 0 works
- 3 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
- 4 Lipid Membrane Structure and Behavior Molecular Biology 0 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 6 Cancer Genomics and Diagnostics Cancer Research 0 works
- 7 Healthcare and Environmental Waste Management Public Health, Environmental and Occupational Health 0 works
- 8 Nanofabrication and Lithography Techniques Biomedical Engineering 0 works
- 9 Political and Social Issues Political Science and International Relations 0 works
- 10 African Studies and Geopolitics Anthropology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Merrimack Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 63% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.